Cargando…

L-Carnitine Is an Endogenous HDAC Inhibitor Selectively Inhibiting Cancer Cell Growth In Vivo and In Vitro

L-carnitine (LC) is generally believed to transport long-chain acyl groups from fatty acids into the mitochondrial matrix for ATP generation via the citric acid cycle. Based on Warburg's theory that most cancer cells mainly depend on glycolysis for ATP generation, we hypothesize that, LC treatm...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Hongbiao, Liu, Ningning, Guo, Haiping, Liao, Siyan, Li, Xiaofen, Yang, Changshan, Liu, Shouting, Song, Wenbin, Liu, Chunjiao, Guan, Lixia, Li, Bing, Xu, Li, Zhang, Change, Wang, Xuejun, Dou, Q. Ping, Liu, Jinbao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3489732/ https://www.ncbi.nlm.nih.gov/pubmed/23139833 http://dx.doi.org/10.1371/journal.pone.0049062

Ejemplares similares

HDAC Inhibitor L-Carnitine and Proteasome Inhibitor Bortezomib Synergistically Exert Anti-Tumor Activity In Vitro and In Vivo
por: Huang, Hongbiao, et al.
Publicado: (2012)

A novel proteasome inhibitor suppresses tumor growth via targeting both 19S proteasome deubiquitinases and 20S proteolytic peptidases
por: Liu, Ningning, et al.
Publicado: (2014)

Intracellular ATP Concentration Contributes to the Cytotoxic and Cytoprotective Effects of Adenosine
por: Li, Shujue, et al.
Publicado: (2013)

Anti-rheumatic agent auranofin induced apoptosis in chronic myeloid leukemia cells resistant to imatinib through both Bcr/Abl-dependent and -independent mechanisms
por: Chen, Xin, et al.
Publicado: (2014)

Clinically used antirheumatic agent auranofin is a proteasomal deubiquitinase inhibitor and inhibits tumor growth
por: Liu, Ningning, et al.
Publicado: (2014)

A microRNA-mediated decrease in eukaryotic initiation factor 2α promotes cell survival during PS-341 treatment
por: Jiang, Lili, et al.
Publicado: (2016)

Repurposing an antidandruff agent to treating cancer: zinc pyrithione inhibits tumor growth via targeting proteasome-associated deubiquitinases
por: Zhao, Chong, et al.
Publicado: (2017)

Gambogic acid induces apoptosis in diffuse large B-cell lymphoma cells via inducing proteasome inhibition
por: Shi, Xianping, et al.
Publicado: (2015)

Inhibition of 19S proteasome-associated deubiquitinases by metal-containing compounds
por: Liu, Ningning, et al.
Publicado: (2015)

Platinum-containing compound platinum pyrithione is stronger and safer than cisplatin in cancer therapy
por: Zhao, Chong, et al.
Publicado: (2016)

Two clinical drugs deubiquitinase inhibitor auranofin and aldehyde dehydrogenase inhibitor disulfiram trigger synergistic anti-tumor effects in vitro and in vivo
por: Huang, Hongbiao, et al.
Publicado: (2015)

Proteasome-associated deubiquitinase ubiquitin-specific protease 14 regulates prostate cancer proliferation by deubiquitinating and stabilizing androgen receptor
por: Liao, Yuning, et al.
Publicado: (2017)

Bilirubin neurotoxicity is associated with proteasome inhibition
por: Huang, Hongbiao, et al.
Publicado: (2017)

Growth arrest and apoptosis induction in androgen receptor-positive human breast cancer cells by inhibition of USP14-mediated androgen receptor deubiquitination
por: Liao, Yuning, et al.
Publicado: (2018)

Targeting proteasome-associated deubiquitinases as a novel strategy for the treatment of estrogen receptor-positive breast cancer
por: Xia, Xiaohong, et al.
Publicado: (2018)

A novel deubiquitinase inhibitor b-AP15 triggers apoptosis in both androgen receptor-dependent and -independent prostate cancers
por: Cai, Jianyu, et al.
Publicado: (2017)

USP10 modulates the SKP2/Bcr-Abl axis via stabilizing SKP2 in chronic myeloid leukemia
por: Liao, Yuning, et al.
Publicado: (2019)

Cytoplasmic RAP1 mediates cisplatin resistance of non-small cell lung cancer
por: Xiao, Lu, et al.
Publicado: (2017)

Carnitine and Depression
por: Liu, Ting, et al.
Publicado: (2022)

HDAC6 regulates IL-17 expression in T lymphocytes: implications for HDAC6-targeted therapies
por: Yan, Bing, et al.
Publicado: (2017)

Inhibition of EGFR signaling with Spautin-1 represents a novel therapeutics for prostate cancer
por: Liao, Yuning, et al.
Publicado: (2019)

Gene spectrum and clinical traits of 10 patients with primary carnitine deficiency
por: Chen, Yao, et al.
Publicado: (2021)

Inhibition of USP14 enhances the sensitivity of breast cancer to enzalutamide
por: Xia, Xiaohong, et al.
Publicado: (2019)

Fatty acid oxidation and carnitine palmitoyltransferase I: emerging therapeutic targets in cancer
por: Qu, Q, et al.
Publicado: (2016)

SRGN crosstalks with YAP to maintain chemoresistance and stemness in breast cancer cells by modulating HDAC2 expression
por: Zhang, Zhijie, et al.
Publicado: (2020)

Pathological Significance and Prognostic Roles of Indirect Bilirubin/Albumin Ratio in Hepatic Encephalopathy
por: Li, Yanling, et al.
Publicado: (2021)

Molecular investigation in Chinese patients with primary carnitine deficiency
por: Zhang, Yanghui, et al.
Publicado: (2019)

Regulation of Bax-dependent apoptosis by mitochondrial deubiquitinase USP30
por: Yan, Ding, et al.
Publicado: (2021)

Microtubule Stabilization by Mdp3 Is Partially Attributed to Its Modulation of HDAC6 in Addition to Its Association with Tubulin and Microtubules
por: Tala,, et al.
Publicado: (2014)

Clinicopathological features and prediction values of HDAC1, HDAC2, HDAC3, and HDAC11 in classical Hodgkin lymphoma
por: Huang, Renhong, et al.
Publicado: (2018)

Endogenous genetic risk factor for serious heatstroke: the thermolabile phenotype of carnitine palmitoyltransferase II variant
por: Oda, Jun, et al.
Publicado: (2018)

Platinum-containing compound platinum pyrithione suppresses ovarian tumor proliferation through proteasome inhibition
por: Huang, Hongbiao, et al.
Publicado: (2017)

Development and validation of an UHPLC-Orbitrap-HRMS method for rapid determination of endogenous L-carnitine in patients on hemodialysis/peritoneal dialysis and its application to promote rational drug use
por: Jiang, Wen-Ting, et al.
Publicado: (2022)

Nickel pyrithione induces apoptosis in chronic myeloid leukemia cells resistant to imatinib via both Bcr/Abl-dependent and Bcr/Abl-independent mechanisms
por: Lan, Xiaoying, et al.
Publicado: (2016)

HDAC6 Deacetylase Activity Is Critical for Lipopolysaccharide-Induced Activation of Macrophages
por: Yan, Bing, et al.
Publicado: (2014)

New HDAC6-mediated deacetylation sites of tubulin in the mouse brain identified by quantitative mass spectrometry
por: Liu, Ningning, et al.
Publicado: (2015)

The Association of Serum L-Carnitine Concentrations with the Risk of Cancer in Chinese Adults with Hypertension
por: Liu, Tong, et al.
Publicado: (2022)

L-Carnitine and Acetyl-L-Carnitine: Potential Novel Biomarkers for Major Depressive Disorder
por: Nie, Li-Juan, et al.
Publicado: (2021)

Proteomic identification and functional characterization of MYH9, Hsc70, and DNAJA1 as novel substrates of HDAC6 deacetylase activity
por: Zhang, Linlin, et al.
Publicado: (2014)

Targeting Ubiquitin–Proteasome System With Copper Complexes for Cancer Therapy
por: Chen, Xin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_j6pk94lqkr3mosp2qqnqcfkjrg